SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-004744
Filing Date
2021-01-08
Accepted
2021-01-08 08:31:56
Documents
72
Period of Report
2020-11-30

Document Format Files

Seq Description Document Type Size
1 10-Q d17792d10q.htm   iXBRL 10-Q 1659857
2 EX-10.4 d17792dex104.htm EX-10.4 79298
3 EX-31.1 d17792dex311.htm EX-31.1 10834
4 EX-31.2 d17792dex312.htm EX-31.2 10833
5 EX-32.1 d17792dex321.htm EX-32.1 4173
6 EX-32.2 d17792dex322.htm EX-32.2 4153
  Complete submission text file 0001193125-21-004744.txt   7689316

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA cydy-20201130.xsd EX-101.SCH 82440
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cydy-20201130_cal.xml EX-101.CAL 44659
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cydy-20201130_def.xml EX-101.DEF 501169
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cydy-20201130_lab.xml EX-101.LAB 550961
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cydy-20201130_pre.xml EX-101.PRE 529890
12 EXTRACTED XBRL INSTANCE DOCUMENT d17792d10q_htm.xml XML 960824
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

IRS No.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-49908 | Film No.: 21515757
SIC: 2834 Pharmaceutical Preparations